HOME WEB INC
10QSB, 2000-11-20
GROCERIES & RELATED PRODUCTS
Previous: TOTAL FILM GROUP INC, 10QSB, EX-27.1, 2000-11-20
Next: HOME WEB INC, 10QSB, EX-10.1, 2000-11-20



                     U.S. SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C.  20549

                                   FORM 10-QSB

(Mark  One)

[X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE
     ACT  OF  1934

For  the  quarterly  period  ended     September  30,  2000
                                   ---------------------------

[ ]  TRANSITION  REPORT  PURSUANT  TO  SECTION  13  OR  15(D)  OF THE SECURITIES
     EXCHANGE  ACT  OF  1934

For  the  transition  period  from                     to
                                  --------------------    ----------------------

Commission  File  Number:  0-30096
                         ------------


                                 HOME.WEB, INC.
        -----------------------------------------------------------------
        (Exact name of small business issuer as specified in its charter)

            NEVADA                                             77-0454933
            ------                                            -------------
(State or other jurisdiction of                             (I.R.S.  Employer
 incorporation or organization)                            Identification No.)

                               8412 ARMSTRONG ROAD
                   LANGLEY, BRITISH COLUMBIA, V1M 3P5, CANADA
                   ------------------------------------------
                    (Address of principal executive offices)

                                 (604) 888-6797
                                 --------------
                 (Issuer's telephone number, including area code)

     Check whether the issuer (1) filed all reports to be filed by Section 13 or
15(d)  of the Exchange Act during the past 12 months (or for such shorter period
that the Registrant was required to file such reports), and (2) has been subject
to  such  filing  requirements  for  the  past  90  days.  Yes [X] No [ ]

     State  the  number of shares outstanding of each of the issuer's classes of
common  equity  as  of  the  latest  practicable date: As of September 30, 2000,
32,876,400  shares  of  Common  Stock,  par  value  $0.001,  were  issued  and
outstanding.

Transitional  Small  Business  Disclosure  Format  (Check  One): Yes [ ] No [X]


                                      - 1 -
<PAGE>
                             HOME WEB, INCORPORATED
                          (A DEVELOPMENT STAGE COMPANY)
                               TABLE  OF  CONTENTS
                                                                         Page
                                                                         ----

PART I - FINANCIAL INFORMATION. . . . . . . . . . . . . . . . . . . . .     3

  Item 1.  Financial Statements . . . . . . . . . . . . . . . . . . . .     3

    Balance Sheets as of September 30, 2000 (Unaudited) . . . . . . . .     3

    Statement of Operations for the nine months ended
    September 30, 2000 and 1999 (Unaudited) . . . . . . . . . . . . . .     4

    Statement of Operations for the three months ended
    September 30, 2000 and 1999 (Unaudited) . . . . . . . . . . . . . .     5

    Statements of Shareholders' Equity for the nine months ended
    September 30, 2000 and 1999 (Unaudited) . . . . . . . . . . . . . .     6

    Statements of Cash Flows for the nine months ended
    September 30, 2000 and 1999 (Unaudited) . . . . . . . . . . . . . .     7

    Summary of Significant Accounting Policies. . . . . . . . . . . . .     8

    Notes to Financial Statements (Unaudited) . . . . . . . . . . . . .     9

  Item 2.  Management's Discussion and Analysis of Financial Condition
           and Results of Operations. . . . . . . . . . . . . . . . . .    12

PART II - OTHER INFORMATION . . . . . . . . . . . . . . . . . . . . . .    15

  Item 1.  Legal Proceedings. . . . . . . . . . . . . . . . . . . . . .    15

  Item 2.  Changes in Securities. . . . . . . . . . . . . . . . . . . .    15

  Item 6.  Exhibits and Reports on Form 8-K . . . . . . . . . . . . . .    15

SIGNATURES. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .    16


                                      - 2 -
<PAGE>
                          HOME WEB, INCORPORATED
                       (A DEVELOPMENT STAGE COMPANY)

                               BALANCE  SHEET
                   As of September 30, 2000 (Unaudited)

ASSETS                                            2000
------                                        ------------

Current assets
     Cash in Bank                             $         0
     Non-trade receivable                           1,450
                                              ------------
            Total current assets              $     1,450

Equipment
     Coolers and equipment                         40,308
     Office equipment                               9,841
                                              ------------
                                                   50,149
     Accumulated depreciation                      (9,288)
                                              ------------
            Total Equipment                        40,861

Other Assets
     Trade name                                    11,000
                                              ------------
            Total other assets                     11,000
                                              ------------
TOTAL ASSETS                                  $    53,311
                                              ============
LIABILITIES & SHAREHOLDER'S EQUITY
----------------------------------

Current liabilities
     Accounts Payable                         $     1,426
     California Franchise Tax payable                   0
     Loan from affiliate                           25,962
                                              ------------
          Total current liabilities                27,388
                                              ------------

SHAREHOLDER'S EQUITY
--------------------
Capital stock                                      27,507
Paid in capital                                 1,347,493
Deficit accumulated during development stage   (1,349,077)
                                              ------------
     Total shareholders' equity                    25,923
                                              ------------

TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY    $    53,311
                                              ============

               See accompanying notes to the financial statements.


                                      - 3 -
<PAGE>
<TABLE>
<CAPTION>
                             HOME WEB, INCORPORATED
                          (A DEVELOPMENT STAGE COMPANY)

                            STATEMENT  OF  OPERATIONS
         For  the  9  months  ended  September  30,  2000  and  1999  (Unaudited)


                                             Nine months ended       September 30, 2000
                                                                        Cash Flows
                                                                     Accumulated During
                                         --------------------------  Development Stage
                                             1999          2000
                                         ------------  ------------  --------------------
<S>                                      <C>           <C>           <C>
Sales                                    $         0   $       528           $    18,887
  Cost of Sales                                    0           523                15,091
                                         ------------  ------------  --------------------
  Gross Margin                                                   5                 3,796

EXPENSES
     Advertising                                                                     856
     Amortization                                                                  1,584
     Consulting Fees                           2,929         5,500                14,125
     Equipment Rental                                                              2,339
     Depreciation                                            3,963                 9,288
     Licenses and Taxes                                        145                   370
     Office Help                                             1,591                12,432
     Office Supplies                              70           588                 3,830
     Postage                                                                         673
     Travel, meals and entertainment                            54                 2,679
     Rent, utilities and telephone                             248                 3,591
     Organization and start up costs                        15,318                41,674
     Compensation due stock issuance                                           1,254,500
                                         ------------  ------------  --------------------
          Total expenses                       2,999        27,407             1,347,941
                                         ------------  ------------  --------------------
          (Loss) from operations              (2,999)      (27,402)           (1,344,145)
                                         ------------  ------------  --------------------

Other Income (expense)
          Interest                                                                    50
          Nondeductible penalties                              716                   882
          State tax expense                      800         1,600                 4,000
                                         ------------  ------------  --------------------
              Total other expenses               800         2,316                 4,932
                                         ------------  ------------  --------------------
              Net Loss                   $    (3,799)  $   (29,718)          $(1,349,077)
                                         ============  ============  ====================
 Loss per share of common stock          $   (0.0001)  $   (0.0010)          $   (0.0410)
Weighted average of shares outstanding    32,876,400    27,157,000            32,876,400
                                         ============  ============  ====================
</TABLE>

               See accompanying notes to the financial statements.


                                      - 4 -
<PAGE>
                             HOME WEB, INCORPORATED
                          (A DEVELOPMENT STAGE COMPANY)

                             STATEMENT OF OPERATIONS
         For the 3 months ended September 30, 2000 and 1999 (Unaudited)

                                                    2000    1999
                                                   ------  ------

EXPENSES
     Consulting Fees                                2,929       -
     Depreciation                                       -   1,321
     Office supplies                                    -       3
                                                   ------  ------

NET LOSS                                           $2,929  $1,324
                                                   ======  ======


              See accompanying notes to the financial statements.


                                      - 5 -
<PAGE>
<TABLE>
<CAPTION>
                             HOME WEB, INCORPORATED
                          (A DEVELOPMENT STAGE COMPANY)

                        STATEMENT OF SHAREHOLDERS' EQUITY
         For the 9 months ended September 30, 2000 and 1999 (Unaudited)

                                      1999

                                                                       Deficit
                               Common Stock                          Accumulated
                               ------------                            During
                                                         Paid  in    Development
                                  Shares     Amount       Capital       Stage       Total
                                ----------  ------------------------------------  --------
<S>                             <C>         <C>        <C>          <C>           <C>
Balance,
December  31,  1998             27,497,000  $ 27,497   $ 1,347,003  $(1,315,513)  $58,987

Common  stock  issued               10,000        10           490                    500

Net  loss  for  the  period                                             (29,718)  (29,718)
  ended  September  30,  1999
                                ----------  ------------------------------------  --------
                                27,507,000  $ 27,507   $ 1,347,493  $(1,345,231)  $29,769
                                ==========  =========  ===========  ============  ========


                                      2000
                                      ----

Balance,
  December  31, 1999            27,507,000  $ 27,507   $ 1,347,493  $(1,345,278)  $29,722


February 23, 2000,
   Forward stock split           5,369,400


Net  loss  for  the  period
   ended  September  30,2000                                             (3,799)   (3,799)
                                ----------  ------------------------------------  --------
                                32,876,400  $ 27,507   $ 1,347,493   (1,349,077)   25,923
                                ==========  =========  ===========  ============  ========
</TABLE>

               See accompanying notes to the financial statements.


                                      - 6 -
<PAGE>
<TABLE>
<CAPTION>
                                               HOME WEB, INCORPORATED
                                           (A DEVELOPMENT STAGE COMPANY)

                                    STATEMENT OF CASH FLOW - INDIRECT METHOD
                       For the nine months ended September 30, 2000 and 1999 (Unaudited)


                                                                2000       1999     September 30, 2000
                                                                                        Cash Flows
                                                                                    Accumulated During
                                                                                    Development Stage
                                                           -------------------------------------------
<S>                                                        <C>          <C>         <C>
CASH
CASH FLOWS FROM OPERATING ACTIVITES
     Net Income (loss)                                     $   (3,799)  $ (29,718)  $      (1,349,077)
Adjustments to reconcile net income to net cash
     Provided by operating activities
     Depreciation and amortization                                  -       3,963               9,288
     Stock issued for services                                      -           -           1,254,500
     Expensing of organizational costs                              -       2,366               2,366
     Attorney fees for stock                                        -         500                 500
     Increases in accounts receivable                               -           -              (1,450)
     Increases in current liabilities                           3,792      22,792              27,388
                                                           -----------  ----------  ------------------
NET CASH PROVIDED BY OPERATING ACTIVITIES                          (7)        (97)            (56,485)

INVESTING ACTIVITIES
     Increase in other assets                                       -           -              13,366
     Purchase of equipment                                          -           -              50,149
                                                           -----------  ----------  ------------------
NET CASH USED IN INVESTING ACTIVITIES                               -           -              63,515
 FINANCING ACTIVITIES
     Sale of common stock                                           -           -             120,000
                                                           -----------  ----------  ------------------
INCREASE (DECREASE) IN CASH AND CASH                               (7)        (97)                  0
Cash and cash equivalents at the beginning of the period            7          97                   0
                                                           -----------  ----------  ------------------

CASH AND CASH EQUIVALENTS AT THE END OF THE PERIOD         $        0   $       0   $               0
                                                           ===========  ==========  ==================
</TABLE>

                 See accompanying notes to financial statements.


                                      - 7 -
<PAGE>
                              HOME WEB, INCORPORATED
                           (A DEVELOPMENT STAGE COMPANY)

                   SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
              For the nine months ended September 30, 2000 and 1999


1.   Development  Stage  Company
     ---------------------------

Home.Web  Inc.  (the "Company") is a development stage company as defined in the
Financial Accounting Standard Board No. 7. The Company is devoting substantially
all  of  its  present  efforts  in securing and establishing a new business, and
although  planned principal operations have commenced, substantial revenues have
yet  to  be  realized.

2.   Use  of  estimates
     ------------------

The  preparation  of  the  financial  statements  in  conformity  with generally
accepted  accounting  principles  requires  management  to  make  estimates  and
assumptions  that affect certain reported amounts and disclosures.  Accordingly,
actual  results  could  differ  from  these  estimates.

3.   Cash  equivalents
     -----------------

For the purpose of the statement of cash flows, the company considers all highly
liquid  debt instruments purchased with the original maturity of three months or
less  to  be  cash  equivalents.

4.   Organization  and  Business  Start  Up  and  Amortization
     ---------------------------------------------------------

Organization  costs  were  expensed  during the period ending March 31, 1999  in
accordance with SOP 98-5.  Management made the election to expense the costs for
years  beginning  January  1,  1999.

5.   Income  Taxes
     -------------

Income  taxes  are  provided for the tax effects of transactions reported in the
financial  statements  and  consist  of  taxes currently due plus deferred taxes
related  primarily  to differences between the recorded book basis and tax basis
of  assets and liabilities for financial and income tax reporting.  The deferred
tax assets and liabilities represent the future tax return consequences of those
differences,  which  will  either  be  taxable or deductible when the assets and
liabilities  are  recovered  or  settle.  Deferred taxes are also recognized for
operating  losses  that  are  available  to offset future taxable income and tax
credits  that  are  available  to  offset  future  federal  income  taxes.

6.   Common  Stock
     -------------

Common stock  is at .001 par value with 50,000,000 shares authorized, 32,876,400
and  27,147,000 outstanding  as of  September  30,  2000  and 1999 respectively.


                                      - 8 -
<PAGE>
                         HOME WEB, INCORPORATED
                     (A DEVELOPMENT STAGE COMPANY)

                  NOTES TO THE FINANCIAL STATEMENTS
   For the three and nine months ended September 30, 2000 and 1999 (Unaudited)

Note  1.  Background
          ----------

The  Company was incorporated under the laws of the State of Nevada on September
15,1995.  The  principal  activities  of  the Company, from the beginning of the
development  stage, have been organizational matters and the sale of stock.  The
Company  was  formed  to  sell  wholesale  gourmet  and  specialty cheese on the
Internet.  During  the period ending September 30, 2000 and 1999 the Company had
sales and incurred expenses against those sales, but the activity was immaterial
for  the  purposes  of  SFAS  No.  7.

Note  2.  Related  Party  Transactions
          ----------------------------

During  the  period ending September 30, 2000 an affiliated company advanced the
Company $20,908.  This money was used to pay off the accounts payable as of June
30, 2000.  There were no material related party transactions for the three-month
period  ending  September  30,  1999.

Note  3.  Income  taxes
          -------------

The  benefit  for  income  taxes  from  operations  consisted  of  the following
components: current tax benefit of $ 5,458 for September 30, 2000 and $ 4,458 as
of  September  30,  1999  resulting  from  a  net  loss before income taxes, and
deferred  tax  expenses  of  $  5,458  and $ 4,458 respectively resulting from a
valuation  allowance  recorded against the deferred tax asset resulting from net
operating  losses.  Net  operating  loss  carry  forward  will  expire  in 2013.

The  valuation  allowance will be evaluated at the end of each year, considering
positive and negative evidence about whether the asset will be realized.  At the
time,  the allowance will either be increased or reduced; reduction would result
in the complete elimination of the allowance if positive evidence indicates that
the  value  of  the  deferred  tax  asset  is  no  longer  required.

Note  4.  Common Stock
          ------------

During the period ending September 30, 1999, pursuant to an exemption under Rule
504of  Regulation  D  of  the  Securities Act of 1933, as amended (the Act), the
Company  sold  solely  to  accredited and/or sophisticated investors, its common
stock.  The  only transaction during the period of September 30, 1999 was 10,000
shares  of  stock issued to the corporate counsel in exchange for legal services
to  the  corporation.

On February 10, 2000, the Board of Directors voted a 1.2:1  forward stock  split
as of the record date of February 23, 2000.


                                      - 9 -
<PAGE>
                         HOME WEB, INCORPORATED
                     (A DEVELOPMENT STAGE COMPANY)

Note  5.  Stock  options
          --------------

It  was  also  voted  upon  at  the  organizational meeting during 1997 to grant
options to officers of the corporation and MVI, an affiliated company along with
one  of  the  employees  of  MVI.  The  options  can be exercised at $.001.  The
options  to  be  exercised  are  1,250,000  and  have no expiration date.  These
options  are considered compensatory and the expense was recognized in the prior
year.

There  were  no  options exercised during the nine-month period ending September
30,  2000.

Note  6.  Property,  equipment  and  depreciation
          ---------------------------------------

Property  and  equipment  are  recorded  at  cost.  Maintenance  and repairs are
expensed as incurred; major renewals and betterments are capitalized. When items
of property and equipment are sold or retired, the related costs and accumulated
depreciation  are  removed from the accounts and any gain or loss is included in
income.

Depreciation  expense  for  the period ending September 30, 2000 and 1999 was $0
and  $3,963  respectively.

Note  7.  Major  customer
          ---------------

The Company had a purchase commitment to purchase the Company's merchandise from
a  non-affiliated  company. This customer is also to take physical possession of
the  Company's  major  assets and use those assets in the ordinary course of its
business.  Terms  are  discussed  more  fully  in  Note  9.

Note  8.  Subsequent  Events
          ------------------

On  October 16, 2000, principal shareholders of the Company returned to treasury
28,800,000  shares  of  Common Stock as contemplated by an Agreement and Plan of
Reorganization  with  Duro  Enzyme Products Inc. executed on August 1, 2000.  On
September  29, 2000, the Company authorized the issuance of 28,800,000 shares of
Common  Stock  of  the  Company to shareholders of Duro Enzyme Products Inc.  On
October  16,  2000,  the  Company  issued  the 28,800,000 shares of Common Stock
pursuant  to  a  voluntary  share  exchange with the shareholders of Duro Enzyme
Products  Inc.  The  28,800,000  shares  issued  to  shareholders of Duro Enzyme
Products  Inc.  represented  over  80%  of  the issued and outstanding shares of
Common Stock of the Company and therefore resulted in a change in control of the
Company.  By  virtue  of this issuance, Home.Web acquired 100% of the issued and
outstanding  capital  of  Duro  Enzyme  Products  Inc.,  which had net assets of
$1,023,515  as  of  September  30,  2000.  Pro  forma net assets of the combined
entities  as of September 30, 2000 were $1,076,826.  For more information on the
business  combination,  please  see  the Home.Web, Inc. report on Form 8-K dated
October  16,  2000  and  filed  on  November  1, 2000, as amended, with the SEC.


                                     - 10 -
<PAGE>
                         HOME WEB, INCORPORATED
                     (A DEVELOPMENT STAGE COMPANY)

Note  9.  Going  Concern
          --------------

As  of  September 30, 2000, the Company had net losses from operating activities
which  raise substantial doubt about its ability to continue as a going concern.

The  Company  is  in  the  process  of  raising initial capital through a public
offering  of  its  common  stock,  which  is expected to provide liquidity until
operations  become  profitable.  The Company has obtained a commitment for up to
$150,000  from  a  significant  shareholder, Monterey Ventures, Inc. for funding
over  the  next twelve months. The funds would be paid distributed in increments
per  requests from the Company on an "as needed" basis. Under the agreement, the
Company  can  repay  the  borrowed  funds  in increments as the Company receives
payment  from  its'  customers. Also in the credit agreement is any funds needed
for  longer  than twelve months would be considered long term debt. This type of
funding,  if  needed, would be structured for a twenty- four or thirty-six month
payoff  not  to  exceed  $  25,000  in requests in the first year of operations.

The  Company has signed an agreement with Internet Food Company to purchase its'
products. Internet Food Company has already penetrated the hotel and gift basket
market  and  has  further  developed  a  web  site  to market its goods. The two
companies  are  in  the  process of identifying specific products that Home Web.
Inc.  would  supply  wholesale.

The  Company's  ability  to  continue  as  a  going  concern is dependent upon a
successful public offering and ultimately achieving profitable operations. There
is  no  assurance  that  the  Company will be successful in its efforts to raise
additional  proceeds  or achieve profitable operations. The financial statements
do  not  include  any  adjustments  that  might  result from the outcome of this
uncertainty.

Note 10.  Stock  Options
          --------------

Stock  that is issued for services rendered is recorded at the fair value of the
stock  in the     year that the stock is given and recorded as an expense in the
same  year.

Note 11.  Material  Adjustments
          ---------------------

Management  represents that all material adjustments to the financial statements
have  been  made.


                                     - 11 -
<PAGE>
ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
--------------------------------------------------------------------------------
OF  OPERATIONS
--------------

This  Form  10-QSB  contains forward-looking statements. The words "anticipate",
"believe",  "expect",  "plan",  "intend", "estimate", "project", "could", "may",
"foresee",  and  similar  expressions  identify  forward-looking statements that
involve risks and uncertainties. You should not place undue reliance on forward-
looking  statements  in  this Form 10-QSB because of their inherent uncertainty.
The  following  discussion  and  analysis should be read in conjunction with the
Financial  Statements and Notes thereto and other financial information included
in  this Form 10-QSB that involve risks and uncertainties.  Actual results could
differ  materially from the results discussed in the forward-looking statements.

BUSINESS

On  October 16, 2000, the Company conducted a  voluntary share exchange with the
shareholders  of  Duro  Enzyme Products Inc.  ("Duro Enzyme") to exchange all of
the issued and outstanding shares of Duro Enzyme for 28,800,000 shares of Common
Stock  of the Company.  The effect of the share exchange was to transfer control
of the Company to the shareholders of Duro Enzyme.  The Company effectively took
control  of  all  of the assets of Duro Enzyme, including its subsidiaries.  The
majority  of  shares  of the Company are now held by former shareholders of Duro
Enzyme.  Following  the  share  exchange, the Company has offices in both Canada
and the United States and has changed the focus of its business from gourmet and
specialty  cheeses  to  recycling  technology.  Its  Canadian  office is located
adjacent  to the site of its prototype DuroZyme Plant and Technology Development
Center  in  Langley,  British  Columbia.

Duro  Enzyme  has  the license to utilize and exploit the DuroZyme Plant and 3SF
Technology  anywhere  in  the world.  Through application of the technology, the
Company  can  manufacture  unique,  stable and natural enzymes and specialty end
products.

This technology solves a major environmental problem and provides the world with
unique,  stable  and  natural  enzyme  products.

Duro  Enzyme  has  two  subsidiaries:

     Duro  Enzyme  Solutions  Inc. ("Duro Solutions USA"), a Nevada corporation,
     ----------------------------------------------------
holds  all the licenses and rights to the 3SF Technology and service as the sole
sublicensor of the technology.  Duro Solutions USA provides technical support to
the  DuroZyme  Plants,  including  quality  control  and assurance functions and
training  in  the  United  States.

     Duro  Enzyme  Solutions  Inc.  ("Duro  Solutions  Canada"),  a  Canadian
     ----------------------------------------------------------
corporation,  is responsible for managing and operating the Company's Technology
Development Center, for carrying out and managing the corporate research and new
product  development,  for protection of intellectual property, and for bringing
new  ideas to commercialization, through research and development contracts with
Thermo  Enzyme  Products  Inc.


                                     - 12 -
<PAGE>
STATUS  OF  OPERATIONS

During  the  nine  months ended September 30, 2000 the operations of the Company
were  suspended.  On October 16, 2000, the Company acquired Duro Enzyme Products
Inc.  The  operations  of the Company after October 16, 2000 consist entirely of
the  business  of  Duro  Enzyme  Products  Inc.

PLAN  OF  OPERATIONS

With  the  acquisition  of  Duro  Enzyme,  the  Company has shifted its business
operations  away  from  gourmet and specialty cheeses to recycling technologies.
The  new  business  is  in  the  early  stages  of  operations and is focused on
implementing  and  developing  its  business plan to meet its growth objectives.
The  majority  of  the current resources of the Company will focus on developing
the  recycling  technologies  of  Duro  Enzyme.

FINANCIAL  CONDITION  AND  RESULTS  OF  OPERATIONS

Nine Months Ended September 30, 2000 Compared to the Nine Months Ended September
30,  1999.

This  information  has  been derived from unaudited interim financial statements
for the periods ended September 30, 2000 and 1999. Results of operations for any
interim period are not necessarily indicative of results to be expected from the
full  fiscal  year.

During  the  third  quarter,  there  was  no significant change in the Company's
financial  condition  or  operations.  The  Company had no sales revenue for the
nine  months  ended  September  30, 2000.  During the third quarter of 1999, the
Company did not have any sales revenue.  The operations of the business had been
suspended  to allow management to review and refocus its direction.  As reported
in the report on Form 8-K dated October 16, 2000 and filed November 1, 2000, the
members  of  the  Board  of  Directors  and  executive officers were replaced on
September  29, 2000.  The new directors and officers will focus their efforts on
the  newly  acquired  business  of  Duro  Enzyme.

LIQUIDITY  AND  CAPITAL  RESOURCES

No  material  commitments  for  capital  expenditures were made during the third
quarter  and  the  expenditures  during  the  fourth  quarter  are not presently
determinable  based  on  the  change  in  management.

However,  the  Company  believes it has sufficient cash resources to operate its
business  over  the  next  twelve months.  Depending on market acceptance of the
Company's  current  business  model,  the  Company  will raise additional funds,
either  debt  or  equity,  to  augment  future  growth  of  the  business.

Management  believes  that current cash balances and cash flows from operations,
if any, will be sufficient to meet present growth strategies and related working
capital  and  capital  expenditure  requirements.  The  current  business  plan
proposes  significant  increases  in  spending  when  compared  to  historical
expenditures.  Management  may  decide  to  raise additional capital through the
issuance  of  additional  debt  or  equity  securities.


                                     - 13 -
<PAGE>
The  Company  plans  to utilize a combination of internally generated funds from
operations,  potential  debt  and / or equity financings to fund its longer-term
growth  over  a  period  of  two  to  five  years.  The  availability  of future
financings  will  depend  on  market conditions.  A portion of the funds will be
needed  to  grow  the  business  through  acquisitions  of  other  businesses.

The  forecast  of  the  period  of  time  through  which the Company's financial
resources  will be adequate to support operations is a forward-looking statement
that  involves  risks  and  uncertainties.  The  actual funding requirements may
differ  materially  from this as a result of a number of factors including plans
to  rapidly  expand  its  new  operations.

EFFECT  OF  FLUCTUATIONS  IN  FOREIGN  EXCHANGE  RATES

The Company's current operations are now located outside the United States.  The
functional  currency  for  this  foreign  operation  is the local currency.  The
carrying  value of the Company's investments in Canada is subject to the risk of
foreign  currency  fluctuations.  Any  revenues  received  from  the  Company's
international  operations  will  be  subject  to  foreign  exchange  risk.

RISK  FACTORS

     THE COMPANY MAY REQUIRE ADDITIONAL EQUITY FINANCING, WHICH MAY NOT BE
     AVAILABLE AND  MAY  DILUTE  THE  OWNERSHIP  INTERESTS  OF  INVESTORS.

The  Company's  ultimate  success will depend on its ability to raise additional
capital.  No  commitments  to  provide  additional  funds  have  been  made  by
management  or  other  shareholders.  The  Company  has  not  investigated  the
availability,  source  or  terms that might govern the acquisition of additional
financing.  When  additional capital is needed, there is no assurance that funds
will be available from any source or, if available, that they can be obtained on
terms  acceptable  to  the  Company.  If not available, the Company's operations
could  be  severely  limited,  and  it may not be able to implement its business
plan.  If  equity  financing  is  used  to raise additional working capital, the
ownership  interests  of  existing  shareholders  may  be  diluted.

     THE COMPANY'S OPERATING RESULTS ARE LIKELY  TO  FLUCTUATE  SIGNIFICANTLY.

As a result of the Company's limited operating history following the acquisition
of  Duro  Enzyme and the planned rapid expansion of its business operations, the
Company's  quarterly  and  annual  revenues  and operating results are likely to
fluctuate  from  period  to  period.  For  this  reason,  you should not rely on
period-to-period  comparisons  of the Company's financial results as indications
of  future results.  The Company's future operating results could fall below the
expectations of public market analysts or investors and significantly reduce the
market  price  of  its  common  stock.  Fluctuations  in the Company's operating
results  will  likely  increase  the  volatility  of  its  stock  price.


                                     - 14 -
<PAGE>
     THE COMPANY'S DEPENDENCE ON RELATIONSHIPS WITH BUSINESSES  AND GOVERNMENTS
     OUTSIDE  OF  THE  UNITED  STATES  INVOLVES  RISKS.

The  Company  depends  on  its  ability  to  establish  and  maintain successful
relationships  with  businesses  and  governments  located outside of the United
States.  If  the Company is unable to establish and maintain such relationships,
it will not be able to implement the business plan in its current configuration,
which  will  affect  both its revenue stream and profit potential.  In addition,
the  Company  faces  political  sovereign  risks  of  conducting  international
business,  including  risks  of  changing  economic conditions, which may have a
material  adverse  effect  on  its  ability  to  expand its operations globally.

     POTENTIAL BUSINESS COMBINATIONS COULD BE DIFFICULT TO INTEGRATE AND DISRUPT
     BUSINESS  OPERATIONS.

Any  acquisition  of  or business combination with another company could disrupt
the  Company's  ongoing business, distract management and employees and increase
the  Company's expenses.  If another company acquires the Company, it could face
difficulties  in  assimilating  with  that  company's  personnel and operations.
Acquisitions also involve the need for integration into existing administration,
services,  marketing,  and  support  efforts.

     THE COMPANY DOES NOT ANTICIPATE PAYING DIVIDENDS TO COMMON SHAREHOLDERS IN
     THE FORESEEABLE FUTURE, WHICH MAKES INVESTMENT IN THE COMPANY SPECULATIVE
     OR RISKY.

The  Company  has not paid dividends on its common stock and does not anticipate
paying  dividends  on  its  common stock in the foreseeable future. The Board of
Directors  has  sole  authority  to  declare  dividends payable to the Company's
shareholders.  The  fact  that  the  Company  has  not  and does not plan to pay
dividends  indicates  that  the  Company  must use all of its funds generated by
operations for reinvestment in its operating activities and also emphasizes that
the  Company  may not continue as a going concern.  Investors also must evaluate
an  investment  in the Company solely on the basis of anticipated capital gains.


                         PART II.     OTHER INFORMATION

ITEM  1.  LEGAL  PROCEEDINGS
----------------------------

None

ITEM  2.  CHANGES  IN  SECURITIES  AND  USE  OF  PROCEEDS
---------------------------------------------------------

None


                                     - 15 -
<PAGE>
ITEM  6.  EXHIBITS  AND  REPORTS  ON  FORM  8-K
-----------------------------------------------

(a)  EXHIBITS.  The  following  exhibits  accompany  this  Form  10-QSB:

EXHIBIT NO.  DESCRIPTION
-----------  -----------
     10.1    License  and  Distribution Agreement between Thermo Enzyme Products
             Inc. and Duro Enzyme Solutions Inc. (U.S.)September 21, 2000

     10.2    Research and Development Services Agreement - Canada between Thermo
             Enzyme  Products  Inc. and  Duro Enzyme Solutions Inc. Canada dated
             September 21, 2000

     10.3    Research and Development Services Agreement United States  between
             Thermo  Enzyme  Products  Inc.  and  Duro  Enzyme  Solutions  Inc.
             (U.S.)  and  Duro Enzyme Products  Inc. dated September 21, 2000

     27.1    Financial Data Schedule

(b)  REPORTS  ON  FORM  8-K.

The  Company  did  not  file  any  reports  on Form 8-K during the quarter ended
September  30,  2000.

                                   SIGNATURES

In  accordance  with the requirements of the Exchange Act, the registrant caused
this  report  to  be  signed  on  its  behalf by the undersigned, thereunto duly
authorized.

HOME.WEB,  INC.


/s/  Robert  Jackman                                        11/20/00
---------------------------                             ---------------
Robert  Jackman,  President                                   Date


                                     - 16 -
<PAGE>
EXHIBIT  INDEX


EXHIBIT NO.  DESCRIPTION
-----------  -----------
     10.1    License  and  Distribution Agreement between Thermo Enzyme Products
             Inc. and Duro Enzyme Solutions Inc. (U.S.)September 21, 2000

     10.2    Research and Development Services Agreement - Canada between Thermo
             Enzyme  Products  Inc. and  Duro Enzyme Solutions Inc. Canada dated
             September 21, 2000

     10.3    Research and Development Services Agreement United States  between
             Thermo  Enzyme  Products  Inc.  and  Duro  Enzyme  Solutions  Inc.
             (U.S.)  and  Duro Enzyme Products  Inc. dated September 21, 2000

     27.1    Financial Data Schedule


                                     - 17 -
<PAGE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission